Abstract
The purpose of this study is to assess the general course of acoustic, patient rated, and clinician-rated voice outcomes from pre- up to 12 months post total laryngectomy.
Methods
Patients admitted to a total laryngectomy in five participating hospitals in Australia and The Netherlands were included. Assessments took place at pre-, 3 months, 6 months, and 12 months post-surgery. Voice outcomes are evaluated with the Acoustic Voice Quality Index (AVQI), perceptual scales, and patient-reported outcome measures including VHI-10 and EQ-5D-5L. Statistical analyses include descriptive statistics, t tests (pre- to 6 months post-surgery), Linear Mixed Effect models.
Results
The study included 43 participants. A significant worsening of AVQI is seen from pre- to post-surgery evaluated with t test (p < 0.001). The Linear Mixed Effect model confirmed Time as a significant factor in predicting AVQI score (p ≤ 0.001), as well as perceptual rated voice quality by the clinician (p = 0.015) and patient-reported perceptual rated voice quality (p = 0.002). No statistical significance was found in VHI-10 scores over time.
Conclusion
Successful TE-speech was achieved in most participants, some had to rely on augmentative alternative communication methods. Patient-reported outcomes indicate acceptance of the condition and sufficient coping in the long term. However, acoustic rated voice quality is abnormal at all post-surgery time-points. AVQI proved to be a useful instrument to evaluate TE-speech. There is a need for validation and determination of cut-off values for VHI-10 and AVQI for use in TE-speech.
Original language | English |
---|---|
Pages (from-to) | 1209–1222 |
Number of pages | 14 |
Journal | European Archives of Oto-Rhino-Laryngology |
Volume | 278 |
Issue number | 4 |
Early online date | 21 Jul 2020 |
DOIs | |
Publication status | Published - Apr 2021 |
Funding
The authors acknowledge Atos medical AB (Malmö, Sweden) for their research grant, which contributes to the existing infrastructure for quality of life research of the Department of Head and Neck Oncology and Surgery at The Netherlands Cancer Institute. Anne Kornman, Merel Latenstein, Nadya van Gent, Katrina Moore, Jodi Gibson, Amy Freeman-Sanderson, Elizabeth Walker, Anne Taranto, and Tia Croft are acknowledged for the support they provided to implement the study procedures as well as their contribution towards the data collection. The Netherlands Cancer Institute receives a research grant from Atos Medical (Malmö, Sweden), which contributes to the existing infrastructure for quality of life research of the Department of Head and Neck Oncology and Surgery. Acknowledgements
Funders | Funder number |
---|---|
Atos Medical AB | |
Netherlands Cancer Institute |